Home Ingredients EpiCor® (Postbiotic Yeast Fermentate — Cargill)
Immune SupportGut Health

EpiCor® (Postbiotic Yeast Fermentate — Cargill)

Saccharomyces cerevisiae
Evidence Level
Very Strong
2 Clinical Trials
7 Documented Benefits
5/5 Evidence Score

EpiCor® is a postbiotic ingredient from Cargill — derived from the fermentation of Saccharomyces cerevisiae (baker's yeast) and one of the most-formulated postbiotic ingredients on the market. Originally developed and clinically validated for immune support (cold/flu symptom reduction, year-round immune support), more recent research has documented direct gut health applications. A randomized double-blind placebo-controlled trial (Pinheiro 2017) showed 500 mg/day EpiCor reduced GI discomfort and constipation symptoms in adults with mild GI dysfunction. In vitro SHIME® gut model studies show EpiCor increases butyrate production, Bifidobacterium abundance, and Lactobacillus colonization — supporting prebiotic-like mechanisms. The honest framing: the bulk of the clinical evidence base (8+ human trials) is on immune outcomes, but legitimate gut-specific evidence exists at the standard 500 mg dose. Useful for both immune support and as a postbiotic for mild GI discomfort/irregularity.

Studied Dose 500 mg/day EpiCor (research-validated)
Active Compound Yeast fermentate from Saccharomyces cerevisiae — beneficial mix of metabolites and bioactive compounds

Benefits

Constipation and GI discomfort reduction

A randomized double-blind placebo-controlled trial (Pinheiro 2017) showed 500 mg/day EpiCor over 12 weeks reduced gastrointestinal discomfort and improved bowel function in adults with mild GI dysfunction. The trial used validated GI questionnaires and demonstrated meaningful symptom improvement vs placebo. This is the strongest direct gut health evidence for EpiCor.

Supported by Trial 1

Cold and flu symptom reduction (primary evidence base)

Multiple RCTs (the largest body of EpiCor evidence) demonstrate reduced incidence and severity of cold and flu symptoms with daily 500 mg supplementation. Effect sizes meaningful as preventive immune support; the immune evidence base is more robust than the gut evidence base.

Supported by Trial 1

Postbiotic mechanism — gut microbiome modulation

In vitro SHIME® gut model studies show EpiCor increases butyrate production (the short-chain fatty acid that fuels colon cells), promotes Bifidobacterium and Lactobacilli growth, and shifts gut microbiome composition. Mechanism foundation for prebiotic-like effects without containing live bacteria.

Supported by Trial 1

Gut-immune axis support

EpiCor's gut microbiome modulation appears mechanistically connected to its immune effects — fermentation in the colon produces metabolites that modulate systemic immunity. Provides comprehensive support spanning both gut and immune endpoints rather than targeting just one.

Supported by Trial 2

Year-round daily use postbiotic

Designed for ongoing daily use rather than acute illness intervention. Postbiotic format (no live bacteria) means heat-stable, shelf-stable, no refrigeration required, and no contraindication for immunocompromised individuals — practical advantages over traditional probiotics.

Pediatric immune research

Recent clinical research specifically in children supports pediatric immune health applications at age-adjusted doses. Useful for parents seeking established postbiotic immune support for school-aged children.

Supported by Trial 2

Honest evidence assessment

The gut health evidence is more limited than the immune evidence — but it does exist (Pinheiro 2017 RCT, in vitro mechanism studies). The Gut Health categorization is defensible based on this evidence, though buyers expecting IBS treatment or major bowel transformation should know that EpiCor is more of a 'general digestive support postbiotic' than a targeted GI therapeutic.

Supported by Trial 2

Mechanism of action

1

Postbiotic Bioactive Compounds

EpiCor contains beneficial mix of metabolites, β-glucans, mannans, polyphenols, peptides, and other bioactive compounds produced during yeast fermentation.

2

Innate Immune Activation

Activates innate immune cells including NK cells, macrophages, and neutrophils — first-line immune defense.

3

sIgA Modulation

Increases secretory IgA in mucosal surfaces — primary antibody at respiratory and GI mucosal barriers.

4

Antioxidant and Anti-Inflammatory Activity

Yeast metabolites provide antioxidant and modest anti-inflammatory effects.

5

Gut Microbiome Modulation

Modulates gut microbiome composition and supports gut-immune communication.

Clinical trials

1
EpiCor for Cold/Flu Reduction — Multiple RCTs
PubMed

Multiple EpiCor 500 mg/day RCTs in healthy adults during cold/flu season.

Healthy adults across studies.

Reduced incidence and severity of cold/flu symptoms; improved respiratory health markers.

2
EpiCor in Children — Recent Research
PubMed

Recently published clinical research on EpiCor in pediatric populations.

Children.

Supports pediatric immune health applications.

Side effects and drug interactions

Common Potential side effects

Generally extremely well-tolerated.
Mild GI distress (rare).
Allergic reactions to yeast possible — relevant for those with yeast/mold allergies.
POSTBIOTIC vs PROBIOTIC — no live bacteria; suitable for immunocompromised.

Important Drug interactions

Generally minimal drug interactions.
Yeast allergy — verify if allergic to baker's/brewer's yeast.
Pregnancy — limited specific safety data; generally considered safe at moderate doses; consult.
Lactation — generally safe.
Children — established pediatric safety; appropriate at proportional doses.
Featured In

Symptom-specific supplement guides

🛡️Best Supplements for Immune Support

More Immune Support Ingredients

Immune Support
Vitamin C
Vitamin C, also known as ascorbic acid, is a water-soluble vitamin commonly used in supple…
Bone Health
Vitamin D
Vitamin D is a fat-soluble vitamin and steroid hormone precursor essential for calcium abs…
Immune Support
Zinc
Zinc, an essential trace mineral, is commonly supplemented in forms like zinc gluconate, a…
Immune Support
Vitamin A
Vitamin A is a fat-soluble nutrient essential for vision, immune function, and cellular gr…

Explore Other Ingredients

Immune Support
Reishi Mushroom
Reishi mushroom, known as the 'mushroom of immortality' in Traditional Chinese Medicine, h…
Immune Support
Turkey Tail Mushroom
Turkey Tail is a polypore mushroom with a long history of use in Traditional Chinese Medic…
Antioxidant
Chlorella
Chlorella is a single-celled freshwater green algae rich in chlorophyll, complete protein…

Frequently asked questions about EpiCor® (Postbiotic Yeast Fermentate — Cargill)

What is EpiCor® (Postbiotic Yeast Fermentate — Cargill)?

EpiCor® is a postbiotic ingredient from Cargill — derived from the fermentation of Saccharomyces cerevisiae (baker's yeast) and one of the most-formulated postbiotic ingredients on the market.

What does EpiCor® (Postbiotic Yeast Fermentate — Cargill) do?

EpiCor contains beneficial mix of metabolites, β-glucans, mannans, polyphenols, peptides, and other bioactive compounds produced during yeast fermentation. In clinical research, EpiCor® (Postbiotic Yeast Fermentate — Cargill) has been studied for constipation and gi discomfort reduction, cold and flu symptom reduction (primary evidence base), postbiotic mechanism — gut microbiome modulation.

Who should take EpiCor® (Postbiotic Yeast Fermentate — Cargill)?

EpiCor® (Postbiotic Yeast Fermentate — Cargill) may be most relevant for people interested in immune support, gut health. It has been clinically studied for constipation and gi discomfort reduction, cold and flu symptom reduction (primary evidence base), postbiotic mechanism — gut microbiome modulation. As with any supplement, consult your healthcare provider before starting, especially if you have medical conditions or take prescription medications.

How long does EpiCor® (Postbiotic Yeast Fermentate — Cargill) take to work?

Most clinical trial effects appear over weeks of consistent use; individual response varies. Acute or same-day effects (where applicable) typically appear within hours, but most cumulative benefits — particularly those affecting biomarkers, mood, sleep quality, or chronic symptoms — require 4-12 weeks of regular use to fully assess. If you don't notice benefit after 12 weeks at the appropriate dose, it may not be your responder.

When is the best time to take EpiCor® (Postbiotic Yeast Fermentate — Cargill)?

For immune support, EpiCor® (Postbiotic Yeast Fermentate — Cargill) can typically be taken in the morning with breakfast. For acute illness use, follow product labeling — dosing frequency and timing may differ from preventive use. Always check product labeling and follow personalized guidance from your healthcare provider.

Is EpiCor® (Postbiotic Yeast Fermentate — Cargill) worth taking?

EpiCor® (Postbiotic Yeast Fermentate — Cargill) has strong clinical evidence (Evidence Level 5/5 on NutraSmarts) for its primary uses, with multiple randomized controlled trials and meta-analyses supporting its benefits. Whether it's worth taking depends on your specific goals, what you've already tried, your budget, and your overall supplement strategy. The honest framing: no supplement is essential for most people, and lifestyle factors (sleep, exercise, diet, stress management) typically produce larger effects than any single supplement. EpiCor® (Postbiotic Yeast Fermentate — Cargill) is most worth trying if its evidence-supported uses align with your specific goals.

What is the recommended dosage of EpiCor® (Postbiotic Yeast Fermentate — Cargill)?

The clinically studied dose for EpiCor® (Postbiotic Yeast Fermentate — Cargill) is 500 mg/day EpiCor (research-validated). Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is EpiCor® (Postbiotic Yeast Fermentate — Cargill) used for?

EpiCor® (Postbiotic Yeast Fermentate — Cargill) is studied for constipation and gi discomfort reduction, cold and flu symptom reduction (primary evidence base), postbiotic mechanism — gut microbiome modulation. A randomized double-blind placebo-controlled trial (Pinheiro 2017) showed 500 mg/day EpiCor over 12 weeks reduced gastrointestinal discomfort and improved bowel function in adults with mild GI dysfunction.